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SUPPLEMENT

Psychological Interventions for Vaccine Injections in Young
Children 0 to 3 Years
Systematic Review of Randomized Controlled Trials and
Quasi-Randomized Controlled Trials
Rebecca Pillai Riddell, PhD,*wz Anna Taddio, BScPhm, MSc, PhD,wy8
C. Meghan McMurtry, PhD,z#** Christine Chambers, PhD, R Psych,ww
Vibhuti Shah, MD, MSc,zzyy88 Melanie Noel, PhD,zz
and HELPinKIDS Team

Background: This systematic review evaluated the eﬀectiveness of
distraction for reducing infant distress during vaccinations in
young children aged 0 to 3 years.
Design/Methods: Database searches identiﬁed relevant randomized
and quasi-randomized controlled trials. Three separate clinical
questions related to variants of the psychological strategy of distraction (directed video; directed toy; nondirected toy) were pursued. Distress was identiﬁed as the critical outcome to assess the
beneﬁts of distraction and extracted from relevant trials. Distress
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was analyzed by phase of procedure (distress preprocedure; distress
acute; distress recovery; idiosyncratic phases based on some or all
of the 3 aforementioned phases).
Results: Ten studies were included in the review. Signiﬁcant results
are presented herein. For directed video distraction, moderate
quality evidence suggested that distress was lowered in the treatment group standardized mean diﬀerence (SMD 0.68 lower [95%
conﬁdence interval (CI), 1.04 to  0.32]) for the acute + recovery
phase as well as the preprocedure phase (SMD  0.49 lower [95%
CI, 7.6 to 0.22]). For directed toy distraction, the analysis of
low-quality evidence for a combined preprocedure + acute +
recovery phase of distress (analysis n = 81), suggested that distress
was lowered in the treatment group (SMD  0.47 lower [95% CI,
 0.91 to  0.02]). An eﬀect for nondirected toy distraction was
also seen, analyzing very–low-quality evidence, for the acute distress phase (n = 290; SMD 0.93 lower [95% CI, 1.86 to 0.00]).
Conclusion: Generally low-quality to very–low-quality evidence
suggests that there may be an eﬀect of directed (toy and video) and
nondirected toy distraction for children aged 0 to 3 years, for
certain phases of the vaccination.
Key Words: infant, toddler, pain management, randomized controlled trial, quasi-randomized controlled trial, systematic review,
vaccination

(Clin J Pain 2015;31:S64–S71)

E

arly childhood is a period of exponential cognitive
development. Although there are similar neural structures involved in infant and older human pain-related
responsivity, the actual coordination and modulation of
stress responsivity has been posited to diﬀer due to developmental stage.1 One key aspect of the infant stage of
development, particularly relevant to psychological strategies such as distraction, is the dependence of the infant on
caregiver for regulation of the distress state. Infants move
from being completely dependent on a caregiver for regulation of distress at birth and move toward self-regulation
by the preschool years.1 This stage of development needs to
be taken into account when understanding eﬀective pain
management strategies.
In the ﬁrst version of a clinical practice guideline about
vaccination pain management by our team HELPinKids
(now Help ELiminate Pain in Kids & Adults), the stage of
infancy was not formally built into the psychological
strategies’ section.2 This current review (and the updated
Clin J Pain
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clinical practice guidelines3) augments previous work by
discussing infant psychological strategies, namely distraction, in a stand-alone review. The emerging cognitive
ability to self-regulate is a pivotal reason why the decision
was made to analyze the impact of distraction interventions
for pain management during vaccination in young children
(0 to 3 y) separately from other age groups in the series of
reviews. This review compliments other work done in this
series where distraction, among other psychological strategies, is handled separately for older children, adolescents,
and adults.4,5 Moreover, the reader’s attention is also
directed to other concurrent reviews in this series in which
infant pain management strategies, such as pharmacological (eg, sucrose, topical anesthetics),6 physical, and
procedural strategies7 are reviewed.
For the purposes of the current review, infant psychological strategies, that is, strategies seen as having a
primarily cognitive mechanism related to modulating infant
pain response, has been limited to the practice of distraction. Given the cognitive development of the infant,
distraction was the only infant pain management strategy
that was seen as having a primarily cognitive mechanism.
In a recent update of an established Cochrane systematic review on nonpharmacological pain management
strategies in young children (0 to 3 y), results from 5
randomized controlled trials were analyzed that included
distraction interventions.8 Two types of distraction were
analyzed—toy and video. Results were analyzed separately
for pain reactivity (< 30 s after needle) and immediate pain
regulation (> 30 s after needle). Low-quality to very–lowquality evidence suggested that while toy distraction had no
eﬀect on pain scores, video distraction did result in lower
scores in the treatment group for both the pain reactivity
and immediate regulation phases.
The current review builds on prior work by broadening
the literature base in which clinical recommendations can be
made to include both quasi-randomized and randomized
controlled trials. The inclusion of these albeit lower quality
trials increases the international generalizability of the
ﬁndings as the inclusion of quasi-randomized trials leads to
the inclusion of research from middle-income countries in
Asia and Europe. Moreover, it allows for the current clinical
practice guidelines to draw upon a greater number of
studies.

METHODS
This review was conducted as a part of the Help
ELiminate Pain in Kids & Adults (HELPinKids&Adults
synthesis and dissemination initiative). One overall search
strategy was used to provide an umbrella search that would
elicit all experimental studies designed to manage vaccination pain. An academic librarian, experienced in systematic reviews, created the search strategy with input from
the clinical lead authors. Tailored searches (inception to
February 26, 2015) were created for 5 databases: EMBASE,
Medline, PsycInfo, CINAHL, and ProQuest Dissertations
& Theses Global. Details of the screening strategy and
extraction methodology are provided elsewhere in this
series.9 The systematic review was registered with PROSPERO and both the Grading of Assessments, Recommendations, Development and Evaluation (GRADE)10 and
Cochrane11 methodologies guided the knowledge synthesis.
Distress was deﬁned as the critically important outcome in this review, as the focus on infants and young
Copyright
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TABLE 1. Clinical Questions and Outcomes for Infant
Psychological Interventions

Clinical Questions
Should directed video
distraction be used
during vaccine
injections in children
0-3 y?
Should directed toy
distraction be used
during vaccine
injections in children
0-3 y?
Should nondirected toy
distraction be used
during vaccine
injections in children
0-3 y?

Critical
Outcomes*
Distress

Distress

Distress

Important Outcomes
Procedure outcomes,
parent fear, use of
intervention,
compliance, memory,
preference, satisfaction
Procedure outcomes,
parent fear, use of
intervention,
compliance, memory,
preference, satisfaction
Procedure outcomes,
parent fear, use of
intervention,
compliance, memory,
preference, satisfaction

*Distress is the critical outcome in the absence of data for pain and/or
fear in individuals incapable of self-report (eg, infants).

children meant that self-report of pain was not possible.
The clinical questions on distraction and the prioritization
of distress for infants were shaped by team discussions of
the larger project with the clinical leads (A.T., C.M.M.,
V.S., R.P.R., C.C., and M.N.) and rated (in terms of
importance) using electronic spreadsheet ballots by the
entire HELPinKids&Adults team. Three clinical questions
on infant distraction studies were agreed upon for inclusion: directed video distraction, directed toy distraction,
and nondirected toy distraction (Table 1). The preﬁx of
“directed” versus “nondirected” was added to delineate
studies where an adult actually attempted to engage the
young child in the distraction, versus studies that simply
exposed an infant to the distractor. When possible, outcomes that were deemed important (rather than critical) by
the team were analyzed for completeness and results are
presented in the Supplemental Digital Content (see SDC
Figures 1 to 3: Supplemental Digital Content 1, http://
links.lww.com/CJP/A243, Supplemental Digital Content 2,
http://links.lww.com/CJP/A244, Supplemental Digital
Content 3, http://links.lww.com/CJP/A245 and SDC
Tables 1 to 3, Supplemental Digital Content 4, http://
links.lww.com/CJP/A246, Supplemental Digital Content 5,
http://links.lww.com/CJP/A247, Supplemental Digital
Content 6, http://links.lww.com/CJP/A248) accompanying
this paper. However, only the critical outcome of distress
will be discussed in this review.
The distinction between the use of distress versus pain
in the current review is predicated on the assumption that
pain is a subjective experience and, therefore, one must be
capable of reliably and validly reporting their pain. In
contrast, distress was seen as a less speciﬁc yet equally
critical outcome for infants’ responses so as not to discriminate against children who cannot self-report. Thus,
our use of the term “distress” does not distinguish between
fear or pain (contrary with the other reviews of older age
spans) because the level of negative impact during the
medical procedure was always obtained through a proxy
(eg, parent report of pain or observational coding of distress behaviors).

2015 Wolters Kluwer Health, Inc. All rights reserved.
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RESULTS
As denoted in Figure 1, a total of 114,251 references
were retrieved from the databases during the umbrella
search. Ten studies14–23 that evaluated directed video distraction, directed toy distraction, and nondirected toy distraction were obtained relevant to the current review and it
was determined that one of the studies was a duplicate (a
thesis and a published manuscript).18
Characteristics of included distraction trials are displayed in Table 2. All included studies provided data for at
least one of the 3 analyses. One study provided treatment
arms for 2 of the 3 clinical questions.19 Two studies provided multiple treatment arms for analyses within the same
clinical question.15,18

Quality of Studies and Risk of Bias
Table 3 shows the results for the risk of bias assessment for critical outcomes. All trials had a high overall risk
of bias primarily because of lack of blinding of important
personnel, and methodological issues related to randomization procedures (ie, allocation concealment and adequate sequence generation).

S66 | www.clinicalpain.com
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Records identified through
database searching
(n = 114251)
Identification

Additional records identified
through other sources
(n = 138)

Total records retrieved
(n = 114389)

Duplicate references
(n = 32155)
Screening

Screened for eligibility
(n = 82234)

Included

The Cochrane risk of bias tool (https://bmg.cochrane.org/assessing-risk-bias-included-studies) was used to
evaluate methodological limitations and the RevMan software program (version 5.2; Cochrane Collaboration,
Copenhagen, Denmark) was used to pool the data. The
eﬀect of each intervention was expressed as a standardized
mean diﬀerence (SMD) with accompanying 95% conﬁdence interval (CI) or relative risk and CI, as appropriate.
A random-eﬀects model was used for all analyses. Statistical heterogeneity was assessed using I2 and w2 tests.3
Distress was also subdivided according to the temporal
phase of the vaccination. Diﬀerent potential factors
relate to infant pain-related distress before the needle,
immediately after the needle, and in the period that follows
the peak distress after needle.12 Accordingly, to characterize
the impact of the intervention on pain-related distress,
distress was analyzed separately for: (1) the preprocedure
phase, which occurred postintervention but before vaccine
injection(s); (2) the acute procedure phase (within the ﬁrst
minute of needle puncture and vaccine injection); and (3)
the recovery procedure phase (1 to 5 min after vaccine
injection(s). In addition, some idiosyncratic combinations
of before needle, needle, and recovery phases were used by
researchers and these were analyzed separately. Pain that
did not occur in the immediate minutes postvaccination (eg,
parents have reported that infant postvaccination pain lasts
beyond the day of injection13) was not analyzed.
Multiple observers may have provided data on the
same outcome (eg, observer-coded child distress, parentrated child distress), data from multiple time points within
the same procedure phase (eg, multiple pain scores in the
ﬁrst minute postvaccination), or both. These multiple data
points were pooled before inclusion in the meta-analysis
using established methods.9
Evidence proﬁles and summary of ﬁndings tables were
created using the GRADE proﬁler software (version 3.6.1)
in which all judgments pertaining to evaluation of quality
of evidence were recorded. When ﬁndings demonstrated
any beneﬁt across critical outcomes, the intervention was
recommended but would be qualiﬁed by the quality of the
evidence.



Studies included in
systematic review
(n = 10)

Duplicate data (thesis
later published)
(n = 1)

FIGURE 1. Flow chart of studies for infant distraction trials.

Overall Quality of Evidence and Treatment
Effects
A quantitative summary of the treatment eﬀects for
available critical outcomes is provided below. Table 4 displays a qualitative summary of these results. Supporting
GRADE Evidence Proﬁles and Summary of Findings
tables for critically important and important outcomes can
be found in the Supplemental Digital Content to the paper.
A full summary of ﬁndings Table with GRADE criteria is
provided for each clinical question.

Should Directed Video Distraction be Used During
Vaccine Injections With Children Between 0 and
3 Years of Age?

Four trials14–17 were included in this analysis with 5
distress outcomes based on temporal phases of the vaccination (distress acute,14,16,17 distress recovery,14 distress
acute + recovery,16 distress preprocedure + acute,15 distress preprocedure14,16). The risk of bias was high in all 4
studies and the overall quality of evidence across studies
ranged from moderate to very low for the 5 distress outcomes evaluated. Quality issues related mainly to
randomization and blinding. Results were mixed across
diﬀerent distress indicators. One moderate quality analysis
(n = 126) revealed a beneﬁt of directed video distraction on
the combined phase of distress acute + recovery: (SMD
0.68 [95% CI, 1.04 to 0.32]). In another analysis of
preprocedure distress (n = 216), there was a positive impact
of directed video distraction: (SMD 0.49 [95% CI, 0.76
to  0.22]). No other distress phase analyses were
signiﬁcant.

Should Directed Toy Distraction be Used During
Vaccine Injections With Children Between 0 and 3
Years of Age?

Five trials17–21 evaluating of the eﬀect directed toy
distraction were included, evaluating 5 distress outcomes
(distress acute,17–21 distress acute + recovery,19,20 distress
recovery,18
distress
preprocedure,19,20
distress

Copyright
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TABLE 2. Characteristics for Included Studies

First
Author
Year,
Country

Injection Details

Population Enrolled, Design,
Setting

Intervention

Critical Outcomes

Should directed video distraction be used during vaccine injections in children 0-3 y?
Vaccines NR; no injection
N = 90; children 2 mo-3 y;
Cohen
Distraction via video and toys (directed
details
between-groups design;
2002,14
by nurses instructed in distraction)
USA
single center, rural health
(n = 49) or control (n = 41)
clinic
12 mo: MMR, H. ﬂu type b, N = 84; children 12 and then Distraction (directed by nurses
Cohen
varicella
200615
18 mo; between-groups
instructed in distraction) (n = 28
(1,2),
18 mo: vaccine NR; no
longitudinal design; single
[12 mo]; n = 14 [18 mo]) or lidocaineUSA
injection details
center, rural health clinic
prilocaine cream 2 g 1 h before the
procedure (n = 28)* or control
(n = 28)
Vaccines NR; no injection
N = 136; children 1-21 mo;
Distraction via video (directed by
Cohen
details
between-groups design;
parents and nurses instructed in
200616
USA
multicenter, hospital and
distraction) (n = 68) or control
outpatient clinic
(n = 68)
DPT, hepatitis or other
N = 350; children 12-30 mo;
Distraction via toy (directed to watch
Gedam
vaccine NR; no injection
between-groups design;
and play—individual directing child
201317
(2),
details
single center; outpatient
not speciﬁed) (n = 120)* or distraction
India
hospital clinic
via video (directed to watch—
individual directing child not speciﬁed)
(n = 120) or control (n = 110)
Should directed toy distraction be used during vaccine injections in children 0-3 y?
N = 117; children 2-24 mo;
Distraction via toy (directed by parent
Cramer- Vaccines NR; no injection
details
between-groups design;
after instruction) (n = 41) or
Berness,
single center; outpatient
distraction via tickling (nondirected)
200519
(1),
clinic
(n = 38)* or control (n = 38)
USA
N = 123; children 2 mo-2 y;
Distraction via toy (directed by parent
Cramer- Vaccines NR; no injection
details
between-groups design;
after instruction) (n = 40) or
Berness
single center; outpatient
supportive care (directed by parent
200520
(1),
clinic
after instruction in use of soothing
USA
strategies) (n = 42)* or control
(n = 41)
DPT, hepatitis or other
N = 350; children 12-30 mo;
Distraction via toy (directed to watch
Gedam
17
vaccine NR; no injection
between-groups design;
and play—individual directing child
2013
(1),
details
single center, outpatient
not speciﬁed) (n = 120) or distraction
India
hospital clinic
via video (directed to watch—
individual directing child not speciﬁed)
(n = 120)* or control (n = 110)
N = 99; children 12-20 mo;
Distraction via toy (directed by
Hillgrove- Vaccines NR; no injection
details
between-groups design;
researcher) (n = 33) or distraction via
Stuart,
single center, outpatient
toy (parent-directed after instruction)
201318
(1,2),
clinic
(n = 32) or control (n = 34)
Canada
DPT; no injection details
N = 90; children 1-3 y;
Distraction via toy (encouraged to watch
Singh
between-groups design;
and touch—individual directing child
2012,21
India
single center, hospital clinic
not speciﬁed) (n = 30) or distraction
via music (encouraged to listen—
individual directing child not speciﬁed)
(n = 30)* or control (n = 30)
Should nondirected toy distraction be used during vaccine injections in children 0-3 y?
Triple vaccines NR IM; 23- N = 50; infants 4 mo; between- Lidocaine-prilocaine 2 g 1 h before
BasiriG 2.5-cm needle; vastus
groups design; single center,
injection (n = 16)* or distraction via
Moghalateralis
outpatient clinic
toy (individual directing distraction
dam
not speciﬁed) (n = 16) or control
201423
(2), Iran
(n = 18)
N = 117; infants and children Distraction via toy (directed by parent
Cramer- Vaccines NR; no injection
details
2-24 mo; between-groups
after instruction) (n = 41) or
Berness
design; single center,
distraction via tickling (directed by
2005,19
(2),
outpatient clinic
parent after instruction) (n = 38)* or
USA
control (n = 38)

Distress: MBPS,
VAS
Distress: MBPS

Distress: MAISD,
VAS
Distress: FLACC

Distress: MBPS,
VAS

Distress: MBPS,
VAS

Distress: FLACC

Distress: MBPS

Distress: Modiﬁed
Objective Pain
Scale (modiﬁed
from FLACC)

Distress: MBPS

Distress: MBPS,
VAS

(Continued )
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TABLE 2. (continued)
First
Author
Year,
Country
Ozdemir
2012,22
Turkey
Singh
2012,21
India

Injection Details
DTaP-IPV-Hib 0.5 mL IM;
23 mm gauge needle; 90
degrees; vastus lateralis;
aspiration for 5-10 s
DPT; no injection details

Population Enrolled, Design,
Setting
N = 120; infants 2 mo;
between-groups design;
single center; outpatient
clinic
N = 90; children 1-3 y;
between-groups design;
single center, hospital clinic

Intervention

Critical Outcomes

Distraction via toy (musical mobile
Distress: FLACC,
aﬃxed to examination table) (n = 60)
cry
or control (n = 60)
Distraction via toy (encouraged to watch Distress: Modiﬁed
and touch—individual directing child
Objective Pain
not speciﬁed) (n = 30) or distraction
Scale (modiﬁed
via music (encouraged to listen—
from FLACC)
individual directing child not speciﬁed)
(n = 30)* or control (n = 30)

Studies were identiﬁed using the following notation: “First Author” “Year of Publication,” “Country” [eg, Taddio 2014, Canada]. If studies contributed to
multiple analyses, then “(#)” was added to enable their discernment (eg, Taddio 2014 [1]).
*Not included in analysis.
Route: IM indicates intramuscular.
Outcomes: Cry indicates cry duration; FLACC, Face, Leg, Activity, Cry, Consolability scale; MAISD, The Measure of Adult and Infant Soothing and
Distress; MBPS, Modiﬁed Behavioral Pain Scale; VAS, Visual Analog Scale.
Vaccines: DPT indicates diphtheria, pertussis, tetanus; DTaP-IPV-Hib, diphtheria, tetanus toxoid, acellular pertussis, inactivated polio vaccine, and
Haemophilus inﬂuenzae type b; MMR, measles, mumps, and rubella.
NR, not reported.

preprocedure + acute + recovery20). The risk of bias was
high in 417,19,20,21 of the 5 studies. Overall quality across
studies ranged from low to very low for the distress outcomes evaluated and results were mixed. Challenges in
quality related mainly to randomization detailing. Using
data from 1 low-quality trial (n = 81), the (SMD 0.47
[95% CI, 0.91 to  0.02]) for a combined phase of distress preprocedure + acute + recovery showed a positive
impact of directed toy distraction on infant distress. No
other distress phase analyses were signiﬁcant.

Should Nondirected Toy Distraction be Used During
Vaccine Injections With Children Between 0 and 3
Years of Age?

Four trials19,21–23 were included in this analysis for 3
distress outcomes (distress acute,19,21–23 distress acute +
recovery,20,22 distress preprocedure20). The risk of bias was
high in all 4 studies. Across the diﬀerent analyses on the 3
distress outcomes, overall quality of the studies meta-analyzed ranged from very low to low and results were mixed.
Quality ratings were impacted due to both issues with
randomization and blinding. Using data from 4 trials
(n = 290), only the results for acute distress showed a
favorable impact of nondirected toy distraction: (SMD
0.93 [95% CI, 1.86 to 0.00]).

DISCUSSION
Building on a broader international research base, the
current systematic review set out to review randomized and
quasi-randomized controlled trials on distraction as a pain
management strategy for distress in young children aged 0
to 3 years. There was some evidence of beneﬁt for directed
video and toy distraction and nondirected toy distraction;
however, beneﬁt was not consistently observed across
phases of the vaccination procedure. The evidence for all
the interventions was generally either of low quality (due to

S68 | www.clinicalpain.com

issues with randomization or blinding) or only based on
evidence from 1 experimental study.
There was little pattern to the signiﬁcance of ﬁndings
due to the use of idiosyncratic time phases. However, it is
perhaps noteworthy that in 2 of the signiﬁcant ﬁndings, a
longer time epoch was used. The reliability of the painrelated distress measurement may have been increased due
to the longer sampling of time on which the distress
measurement was based. By reducing the noise of the
measurement this may have increased the probability of
showing a signiﬁcant eﬀect. Conversely, adding to the noise
of measurement within our analyses was the age diﬀerences
across studies.
As mentioned, infancy is a period encompassing the
steepest trajectory of development across the lifespan. Both
individual studies and our analyses of studies often synthesized
ﬁndings based on infants and young children from 2 months
up to 3 years. Developmentally, this type of averaging
obscures our understanding of pain management. A recent
age-sensitive analysis of developmental diﬀerences in infant
pain responsivity over the ﬁrst year of life clearly demonstrated
that researchers who conduct infant pain management
randomized controlled trials must pay greater attention to age
diﬀerences within infancy.24 Moreover, the receptivity of
infants to distraction is hypothesized to vary due to developing
motor and cognitive capacities. On the basis of developmental
milestones, a 2-month old would seem less oriented to beneﬁt
from distraction. However, a child older than 12 months
would seem to have greater ability to beneﬁt from distraction,
owing in part to the emerging ability to enjoy joint attention
with a caregiver and the motor control to manage self-orientation to an external stimulus.
Furthermore, because of the central importance of the
primary caregiver to understanding pain responses and
management in early childhood,25 another important factor
to incorporate into trials is the agent of distraction is (ie,
who is doing the distracting), whether it is a primary
caregiver, nonprimary caregiver, nurse, or physician.
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TABLE 3. Assessment of Risk of Bias of Included Trials for Critical Outcomes

First Author Year

Adequate
Sequence
Generation

Blinding of
Allocation Participants and
Concealment
Personnel

Blinding of
Outcome
Assessment

Should directed video distraction be used during vaccine injections in children 0-3 y?
No
No
No
Unclear
Cohen 200214
No
No
No
Unclear
Cohen 200615
(1,2)
Yes
Yes
Unclear
Unclear
Cohen 200616
No
No
Unclear
Yes
Gedam 201317
(2)
Should directed toy distraction be used during vaccine injections in children 0-3 y?
Cramer-Berness
Unclear
Unclear
No
No
200519
Unclear
Unclear
Yes
Yes
Cramer-Berness
200520 (1)
Gedam 201317
No
No
Unclear
Yes
(1)
Hillgrove-Stuart
Yes
Yes
Yes
Yes
201318 (1,2)
(+ thesis)
Singh 201221
No
No
No
Unclear
Should nondirected toy distraction be used during vaccine injections in children 0-3 y?
No
Unclear
No
No
BasiriMoghadam
201423 (2)
Cramer-Berness
Unclear
Unclear
No
No
200519 (2)
22
Ozdemir 2012
No
No
No
Yes
No
No
No
Unclear
Singh 201221

Incomplete
Outcome Data
Addressed

Free of
Selective
Reporting

Free of
Other
Bias

Overall
Risk

Yes
No

Yes
Yes

Yes
Yes

High
High

No
Yes

Yes
No

Yes
Unclear

High
High

Yes

Yes

Yes

High

Unclear

Yes

Yes

High

Yes

No

Unclear

High

Yes

No

Yes

Low

Yes

Yes

Yes

High

Yes

Yes

Yes

High

Yes

Yes

Yes

High

Yes
Yes

Yes
Yes

No
Yes

High
High

Studies were identiﬁed using the following notation: “First Author” “Year of Publication” [eg, Taddio 2014]. If studies contributed to multiple analyses,
then “(#)” was added to enable their discernment (eg, Taddio 2014 [1]).

Although 1 trial did address this question with null
results (hypothesized because of the short amount
of time in which the distractor was used across treatment
groups), this implementation factor should be more systematically investigated18 in trials discerning the impact of
distraction for early childhood pain management during
vaccination.
The promising ﬁndings on video distraction for both
the preprocedure phase and the acute + recovery phase
mirrored the updated Cochrane Review8 recommendations,
a review based solely on randomized controlled trials. This
is despite the inclusion in the current review of a large
nonrandomized controlled trial that was not a part of the
Cochrane analysis.17 However, the ﬁndings on the toy
distraction disagreed with the updated Cochrane Review on
the topic, which did not ﬁnd an eﬀect of toy distraction,
regardless of the phase of the vaccination. The results of
the current review may have diﬀered due to the inclusion
of 3 additional studies.15,19,21 Thus, based on analyses
within the current review, weak recommendations are
being made for both toy and video distractors. However,
further work should explore other types of distraction
that may be especially helpful during the infant and
early childhood stage of development (eg, face-to-face
engagement with a caregiver while cradled for young
infants).
Another possible reason for the equivocal results of
distraction across distress outcomes within this review may
relate to the timing of distraction—speciﬁcally, there may
be speciﬁc times during vaccination when distraction may
Copyright
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be optimally engaged to help young children. Observational
and experimental research has shown that infants who are
distressed before the needle will have higher pain scores
after the needle.18,26 Thus, there would be suﬃcient reason
to hypothesize that distraction should begin early enough
to suﬃciently engage a child before the needle, thus mitigating the acute and recovery pain responses after needle.
Conducting a randomized controlled trial where distraction
is initiated at a number of diﬀerent intervals (eg, 1 min
before needle [no distress], right after needle [high distress],
2 min after needle [moderate distress]) with strict controls to
equalize proximity to caregiver among treatment groups
would help clarify this issue.
Although distraction may oﬀer some beneﬁts in
reducing child distress during vaccination, observational
research suggests that it is not a commonly occurring
strategy during routine infant vaccine injections. In the
largest longitudinal observational study conducted during
infant immunization, including over 760 parent-infant
dyads,27 the natural occurrence and eﬀects of parental use
of distraction were examined over the ﬁrst year of life.
Systematic analyses suggested a clear developmental trend
in the naturalistic use of distraction (ie, distraction techniques that parents employed with no coaching). Parents used
distraction increasingly as the infant aged from 2 to 12
months. However, even at 12 months, during any given
phase of the vaccination (ie, preprocedure, acute after
needle, recovery before needle) the maximum average
amount of time that parents used distraction hovered
around 10%. Current parental practices during routine
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TABLE 4. Summary of Results for Critically Important Outcomes
for Infant Psychological Interventions

Clinical Questions

Quality
Critical
Beneﬁt of
of
Outcomes* Interventionw Evidencez

Should directed video
Distress
distraction be used
during vaccine
injections in children
0-3 y?
Should directed toy
Distress
distraction be used
during vaccine
injections in children
0-3 y?
Should nondirected toy Distress
distraction be used
during vaccine
injections in children
0-3 y?

Mixed

Very low

Mixed

Very low

Mixed

Very low
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attunement to early childhood throughout analysis and
interpretation. There is suﬃcient evidence from these
studies to weakly suggest that there may be some beneﬁt for
distraction via toy and video to infants and young children
(0 to 3 y), whether directed or nondirected; albeit the eﬀect
is not robust. The use of distraction during early childhood
should not interfere with a young child’s core developmental need for proximity to the caregiver during times
of pain-related distress.25
Although the feasibility of video distraction in lowresource environments is challenging, other types of distraction (eg, toys, car keys, objects in clinic setting) can be
low cost, easily transferable interventions with minimal
impact to clinical ﬂow. Moreover, researchers should focus
their attention on rigorous trial execution that considers
developmental stage and timing of the distraction more
closely and the interaction between distraction and other
measures of infant soothing (eg, holding).
REFERENCES

*Includes results for the critical outcomes that were evaluated in
included studies only.
wThe results for the eﬀect of the intervention have been summarized
across the critical outcome of distress, and are expressed using the following
notation: Yes = beneﬁt was observed for all measurements of the critical
outcome; Mixed = beneﬁt was observed for at least 1 measurement of the
critical outcome; No = no evidence of beneﬁt was observed for any of the
measurements of the critical outcome.
zReﬂects the lowest quality of evidence rating across all evaluated critical outcomes, whereby rankings range from High to Moderate to Low to
Very low.

immunizations, namely the natural occurrence yet mixed
eﬀectiveness, further strengthens the justiﬁcation for more
research on the role of distraction as a pain management
strategy in early childhood.
Although strict protocols for systematic reviews were
followed in the current review, there are a number of limitations that warrant caution. First, the quantity and
quality of the studies are not adequate to base strong recommendations in either direction. Moreover, as noted
earlier, the age of children in most of these studies
encompassed large developmental spans during infancy.
Despite this knowledge, the paucity of literature did not
permit more ﬁnely grained age analyses in this review.
Another limitation that is pertinent to understanding distraction on the infant is the role of holding. The position of
the child is a crucial element to the execution of distraction;
therefore, future researchers on this topic are strongly
encouraged to provide this methodological detail. On the
basis of evidence presented elsewhere in this series,7 it is
posited that holding an infant in the caregivers’ arms is the
optimal position for distraction in young infants (ie, less
than 1 y of age), whereas the exact positioning of older
infants (eg, toddlers over 1 y of age) in relation to the
caregiver should depend on child preference. Finally, given
the lack of any correction applied to the entire set of
analyses, there is a chance that one of the positive results
reﬂects type II error (the existence of a signiﬁcant eﬀect
when in fact no such eﬀect exists).
Despite these limitations, the current review adds to
the literature base for pain management for vaccination due
to the use of a stringent methodology, the attention paid to
temporal phases of the vaccination, and a developmental
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